KAWASAKI DISEASE
Clinical trials for KAWASAKI DISEASE explained in plain language.
Never miss a new study
Get alerted when new KAWASAKI DISEASE trials appear
Sign up with your email to follow new studies for KAWASAKI DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart-Saving combo: steroid plus standard therapy may shield kids from kawasaki damage
Disease control CompletedThis study looked at whether adding a steroid called prednisolone to the usual treatment (immunoglobulin and aspirin) could reduce heart artery damage in children with Kawasaki disease. Over 3,200 children took part. The goal was to see if the combination therapy lowers the chanc…
Matched conditions: KAWASAKI DISEASE
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy aims to stop heart damage in kids with kawasaki disease
Disease control CompletedThis early-phase study tested a combination of atorvastatin and anakinra in 5 children with Kawasaki disease who had coronary artery abnormalities. The goal was to see if these drugs could safely reduce artery inflammation and prevent future heart problems. The study focused on s…
Matched conditions: KAWASAKI DISEASE
Phase: EARLY_PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Kawasaki Kids' hearts under the microscope 5 years later
Knowledge-focused CompletedThis study looked at the heart health of 61 children who had Kawasaki disease 5 years earlier and were treated with IVIG. Researchers compared them to healthy children using blood tests, blood pressure, artery stiffness, and heart imaging. The goal was to find early signs of hear…
Matched conditions: KAWASAKI DISEASE
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC